The prospects of cariprazine in the treatment of schizophrenia

被引：6
|
作者：
Scarff, Jonathan R. [1 ]
机构：
[1] Dept Vet Affairs, Community Based Outpatient Clin, 279 North Grove Med Pk Dr, Spartanburg, SC 29303 USA
来源：
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY | 2017年 / 7卷 / 11期
关键词：
RECEPTOR PARTIAL AGONIST; NEGATIVE SYMPTOMS; MODEL;
D O I：
10.1177/2045125317727260
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：237 / 239
页数：3
相关论文
共 50 条
  • [31] TREATMENT OF SCHIZOPHRENIA - PROGRESS AND PROSPECTS - WEST,LJ
    FELMLY, ML
    PSYCHIATRIC ANNALS, 1978, 8 (09) : 493 - 493
  • [32] Kynurenine Aminotransferases and the Prospects of Inhibitors for the Treatment of Schizophrenia
    Jayawickrama, Gayan S.
    Sadig, Richard R.
    Sun, Guanchen
    Nematollahi, Alireza
    Nadvi, Naveed A.
    Hanrahan, Jane R.
    Gorrell, Mark D.
    Church, W. Bret
    CURRENT MEDICINAL CHEMISTRY, 2015, 22 (24) : 2902 - 2918
  • [33] Safety profile of cariprazine: Post hoc analysis of safety parameters of pooled cariprazine schizophrenia studies
    Szatmari, B.
    Barabassy, A.
    Laszlovszky, I.
    Harsanyi, J.
    Acsai, K.
    Burjan, A.
    Sebe, B.
    Earley, W.
    Patel, M.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S419 - S419
  • [34] Cariprazine as a maintenance treatment in dual schizophrenia: a 6-month observational study in patients with schizophrenia and cannabis use disorder
    Szerman, Nestor
    Vega, Pablo
    Roncero, Carlos
    Peris, Lola
    Grau-Lopez, Lara
    Basurte-Villamor, Ignacio
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2025, 40 (03) : 167 - 175
  • [35] Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
    Citrome, Leslie
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 2563 - 2577
  • [36] Global improvement with cariprazine in the treatment of bipolar I disorder and schizophrenia: A pooled post hoc analysis
    Durgam, Suresh
    Earley, Willie
    Lu, Kaifeng
    Nemeth, Gyorgy
    Laszlovszky, Istvan
    Volk, Stephen
    Litman, Robert E.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (12)
  • [37] Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy
    Leslie Citrome
    Advances in Therapy, 2013, 30 : 114 - 126
  • [38] The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
    Nasrallah, Henry A.
    Earley, Willie
    Cutler, Andrew J.
    Wang, Yao
    Lu, Kaifeng
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    Durgam, Suresh
    BMC PSYCHIATRY, 2017, 17
  • [39] Safety and tolerability of cariprazine in long-term treatment of schizophrenia: integrated summary of safety data
    Nasrallah, H. A.
    Cutler, A. J.
    Wang, Y.
    Lu, K.
    Nagy, K.
    Laszlovszky, I.
    Durgam, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S536 - S536
  • [40] Cariprazine for the Treatment of Bipolar Disorder
    Findlay, Lillian Jan
    El-Mallakh, Peggy L.
    El-Mallakh, Rif S.
    PERSPECTIVES IN PSYCHIATRIC CARE, 2017, 53 (03) : 148 - 155
12345